🎁 Black Friday: up to 50% off of annual plans
OK Biotech Co., Ltd. (TPE:4155)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.50
-0.70 (-4.32%)
Nov 20, 2026, 1:30 PM CST

OK Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
413.05314.47277.46323.03596.42599.85
Trading Asset Securities
11.2912.5913.0442.3140.2344.78
Cash & Short-Term Investments
424.35327.06290.5365.34636.64644.64
Cash Growth
34.35%12.58%-20.48%-42.61%-1.24%13.75%
Accounts Receivable
600.62383.12560.19439.36383.27376.79
Other Receivables
9.7526.7228.3149.2326.2128.11
Receivables
610.37409.84588.5488.59409.47404.9
Inventory
431.05456530.54394.05422.95375.64
Prepaid Expenses
52.69--64.4749.4757.76
Other Current Assets
7.7556.3663.134.917.986.06
Total Current Assets
1,5261,2491,4731,3171,5271,489
Property, Plant & Equipment
2,0692,0281,627865.71874.73659.4
Long-Term Investments
37.3423.3622.24358.92458.52482.25
Goodwill
-353.52353.5223.6323.6329.63
Other Intangible Assets
434.71111.56124.971.798.9516.12
Long-Term Deferred Tax Assets
66.717262.3457.1151.1544.28
Other Long-Term Assets
1411.4132.39442.84117.7192.09
Total Assets
4,1483,8493,6953,0673,0612,813

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
175.51140.42258.32203.8244.63240.4
Accrued Expenses
-38.8644.1921.3151.3326.03
Short-Term Debt
210295305155.03185.73187.04
Current Portion of Long-Term Debt
-10.1955.4679.62205.64142.8
Current Portion of Leases
6.4810.743.823.193.122.26
Current Income Taxes Payable
18.532.2411.87-33.76-
Current Unearned Revenue
74.1123.0448.4490.3267.8353.87
Other Current Liabilities
265.6327.1317.6724.8636.1448.16
Total Current Liabilities
750.26547.6744.76578.13828.18700.55
Long-Term Debt
775.8606.4632291.94382.97401.76
Long-Term Leases
75.9490.7633.772.173.17-
Long-Term Deferred Tax Liabilities
23.5725.1727.85-0.43-
Other Long-Term Liabilities
3.323.320.020.020.027.43
Total Liabilities
1,6291,2731,128672.261,2151,110

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,2521,4481,4711,458995.02949.34
Additional Paid-In Capital
846.28--922.29600.99562.02
Retained Earnings
423.63263.7247.53158.06268.07203.67
Comprehensive Income & Other
-60.72801.34773.95-140.19-19.46-10.52
Total Common Equity
2,4612,5132,4922,3981,8451,705
Minority Interest
57.7862.9374.84-2.761.79-1.5
Shareholders' Equity
2,5192,5762,5672,3951,8461,703
Total Liabilities & Equity
4,1483,8493,6953,0673,0612,813

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,0681,013720.05331.95780.63733.86
Net Cash (Debt)
-643.87-686.09-429.5533.39-143.98-89.22
Net Cash Growth
------
Net Cash Per Share
-5.05-5.25-3.270.29-1.23-0.84
Filing Date Shares Outstanding
128.72126.49128.23130.6698.2993.78
Total Common Shares Outstanding
128.72126.49128.23130.6698.2993.78
Working Capital
775.95701.65727.9739.22698.33788.44
Book Value Per Share
19.1219.8719.4318.3518.7718.18
Tangible Book Value
2,0262,0482,0142,3721,8121,659
Tangible Book Value Per Share
15.7416.1915.7018.1618.4317.69
Land
-417.61417.61417.61417.61185.4
Buildings
-345.47345.47345.04344.72343.3
Machinery
-342.51321.15320.7286.11190.59
Construction In Progress
-1,124791.920.5116.0193.21